NEW YORK (GenomeWeb News) – Roche said this week that it has appointed Daniel O'Day, current COO of Roche Diagnostics, to be COO of Roche Pharma, taking over for Pascal Soriot, who has left the firm to become CEO of AstraZeneca. Roland Diggelmann will succeed O'Day as COO of Roche Diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.